Spleen Weight in Rats During Tumour Growth and in Homograft Rejection by Blamey, R. W. & Evans, D. M. D.
527
SPLEEN WEIGHT IN RATS DURING TUMOUR GROWTH
AND IN HOMOGRAFT REJECTION
R. W. BLAMEY* ANDD. M. D. EVANS
From theSurgical Unit and Cardiff and District group Laboratory and Tenovus
Institutefor Cancer Research, Cardiff
Received for publication January 11, 1971
SUMMARY.-The spleens of rats bearing methylcholanthrene induced
sarcomas are enlarged. This applies both to primary and to isotransplanted
tumours. The spleen enlarges with increasing tumour size.
Splenomegaly is induced by skin homograft rejection, but spleen sizes do
not reach those seen during tumour growth, even when the animals are
chronically exposed to homologous skin. Sensitization of animals with small
tumour homografts gives spleen sizes even greater than those of primary
tumour growth.
Spleen histology in tumour bearing animals is comparable with that of
homograft rejection.
The relation of splenomegaly to the presence of tumour specific antigen is
discussed. The suggestion is advanced that the spleen size during tumour
growth is determined by the product of reaction to foreign antigen, and of
reticuloendothelial (phagocytic) activity.
WOODRUFF AND SYMES (1962a, b) have argued that s lenomegaly aocom-
panying tumour growth denotes the presence of tumour specific antigen. They
based their conclusion on observations of mammary carcinomas in A-strain mice.
These tumours have not been shown by transplantation experiments to carry
such antigens, whereas chemically induced sarcomas in mice and rats are known
to possess strong tumour specific antigens (Baldwin, 1955; Old, Boyse, Clarke
and Carswell, 1962).
This paper reports spleen weights and histological changes in the spleens of
rats bearing chemically induced sarcomas. The spleens of animals rejecting
homografts ofskin or oftumour, and ofanimals after chronic exposure to foreign
histocompatability antigens, are also studied.
MATIMRIALS AND METHODS
Animals
An inbred strain of Wistar rats, obtained originally from the Laboratory
Animals Centre, and a commerciaRy available strain of non-inbred black-hooded
rats, were used for the experiments.
Experiment I
Tumours were induced by a subcutaneous injection of 0-5 ml. of 0-6%
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20-methyleholanthrene in arachis oil, to the females ofthe inbred strain of Wistar
rats, aged 3 to 9 months at the time ofinjection. Tumours all became palpable
between the 10th and 26th week afterinjection.
Where first generation tumour isotransplants were used, the passage was
carried out by the subcutaneous implantation of a small piece of tumour (around
g. weight).
Tumours were measured daily and the mean of 2 diameters at right angles
recorded. The majority of these animals were killed when the tumour had
reached 4 cm. mean diameter, but some were killed earlier than this. On killing
the animals the tumour was removed; tumour weight and body weight were
obtained separately; the spleen was removed, weighed and kept for histology;
and a mesentericlymph node and a liverbiopsy taken forhistology. The tumours
were biopsied when removed and all were found to be spindle cell sarcomas. The
ratsweighed 175 to 250 g. (excluding theweight ofthe tumours).
Experiment 2
Skin homografts were carried out from non-inbred black-hooded rats to the
Wistar rats. Female rats of 200-275 g. were used as donors and recipients.
Donors and recipients were matched to be within ± 10 g. of each other, and the
donors were used as the control animals. Spleen weights of these Wistar and
black-hooded strains were not significantly different. Grafts were approximately
I cm. square, full-thickness and were sewn intoplace without a dressing. On the
9th day after grafting both donor and recipient were killed, and their tissues
removed.
Experiment 3
Non-inbred black-hooded rats were sensitized to the tumours of the inbred
Wistars, by the subcutaneous implantation to 2 or 4 limbs of pieces of tumour
each approximately I g.; 5-21 days after sensitization the animals were killed
and tissues removed as before.
Experiment 4
To obtain chronic exposure to foreign histocompatability antigen, 5 female
Wistar rats were paired with 5 female black-hooded rats. Pieces of skin from the
black-hooded rats were taken at intervals and buried subcutaneously on the
partner Wistar. To simulate tumourgrowth thepieces ofskin used were increased
in size at eachtransplant. Three weeks after the lasttransplant the animals were
killed and tissues removed as before.
In all experiments ether anaesthesia was used.
RESULTS
Experiment I
The spleenweights ofinbred Wistar rats withlarge tumours as compared with
those of non-tumourous animals of the same strain are shown in Table 1. Both
primary and isotransplanted tumours are seen to excite splenomegaly when the
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TABLE I.-MeanSpleen Weights ofInbred Female Rat-9 with Large
Methylcholanthrene Sarcomas (More than 4 cm. Diameter)
Spleen weight
Mean body
A
weight Mean Mean Significance Animals No. (gm.) (gm.) difference (p)
Primary tumours 25 214 1-58
1-11+0-21 <0-001
No tumours 19 200 0- 48
1-31+0-22 <0-001
Isotransplanted tumours 18 223 1-79
TABLE II.-Di8tribution ofSpleen Weights Against TumourSize, in Animals
withPrimary Methylcholanthrene Sarcomas
Spleen weight (gm.)
A
Tumour size No. <1 1-1-5 1-5.-2 >2
No tumours 19 17 2
Tumours at 6) cm. 7 2 4 1
4 cm. 25 6 8 8 3
TABLE III.-Di8tribution ofSpleen Weight8 Against l'umourSize, in Anima18
with Isotransplanted Methylcholanthrene Sarcomas
Spleen weight (gm.)
A
Tumour size No. < I 1-1 .5 1-5L2 > 2
No tumours 19 17 2
Tumours at 2 cm. 14 10 "I0
4 cm. 18 3 6 3 6
Tables 11 and III show the distribution ofspleen weights against tumour size
of primary and isotransplanted methylcholanthrene tumours. A tendency to
increase in spleen size withincreasing tumour size is seen. In Table IV the spleen weights of a series of animals with tumour isotransplants of less than 2 cm. in
diameter are shown against controls matched for weight. There is a significant increase in spleen weight in the tumour-bearing animals, but this is not as great
as that shown with the larger tumours.
TABLE IV.-MeanSpleen Weight ofAnimals with I8otransplant8 ofTumour Groum
to Less than 2 cm. Mean Diameter When Animal Killed, Against that ofPaired
Controls.
Meanspleen
weights Mean Significance Animals No. (gm.) Difference (P)
Controls (paired) 13 0- 72
0-34±0-13 0-02<.P<0-01
Tumour isotransplants 13 1-06
Thespleenhistology ofanimals with tumours more than 4 cm. diameter showed
an increased cellularity when compared with that of normal animals; this was
greatest in the interfollicular pulp. There was an increase in the number of
giant cells present, and these cells had more lobules to their nuclei. The changes
were seen with both primary and isotransplanted tumours, and animals with
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spleen size and thelength ofthe latent period betweeninjection ofmethylcholan-
threne and appearance oftumour, the mean latent period being 21 weeks.
Experiment 2
Mean spleen weights of animals during first set skin homograft rejection are
shown in Table V, compared with ungrafted controls. The mean time of graft
rejectio'n, judged clinically, was approximately 9days.
TABLEV.-MeanSpleen Weight8ofRat8During Homograft Rejection (9 Days
after Grafting) Compared with Donor Controls
(Experiment 2)
Meanbody Mean spleen
weights weights Mean Significance
Animals No. (gm.) (gm.) difference (P)
Donors 15 241 0- 65
0-42±0-14 <0-01
Recipient 19 248 1-07
Experiment 3
Thespleenweights ofblack-hooded rats sensitized with subcutaneousimplants
of Wistar tumours are show-n in Table VI. Some 200 implants of these tumours
were made to black-hooded rats and only 3 implants were observed to grow.
One of these induced a spleen weiLyhina 9 g. in its new host, much the largest qLjl 'L.J' spleen seen in any experiment. The histology of the spleens of these animals
sensitized to homologous tumour, including the 3 in which these tumours grew,
were similar to that in animals with primary and isotransplanted tumour.
TABLF, VI.-Spleen Weight8 ofBlack-hooded Rat8 Sensitized to Wi8tar
Methylcholanthrene, Tumour8
(Experiment 3)
Spleen weight (gm.)
Animals No. < 1 1-2 2-3 > 4
Controls-unsensitized 14 14 - -
Sensitized with homologous tumour 28 - 12 6 10
Experiment 4
Thespleenweights ofWistar ratsexposed to a chronicantigen stimulus ofskin
from black-hoodedrats, are shown in Table VII. Controls wereungrafted Wistar
rats, paired by weight. Spleen histology in this group surprisingly showed little
change from normal, and did not resemble that seen during tumourgrowth.
TABLE VII.-MeanSpleen Weights ofAnimaM After Chronic Exposure to
Homografted Skin BuriedSubcutaneously
(Experiment 4)
Meanspleen Mean Significance Animals No. weight (gm.) difference (P)
Controls (paired) 5 0-63
0-52±0-26 . O-I<P<0-05
Grafted . 5 1.15531 SPLEEN IN TUMOUR GROWTH AND HOMOGRAFT REJECTION
DISCUSSION
Woodruff and Symes (1962a, b) have reported splenomegaly in A-strain mice
bearing spontaneous mammary carcinomas. These spleens showed follicles with
many activated lymphoid cells, and many pyronophilic ceHs in the red pulp-;
and Woodruff and Symes interpreted this picture as showing changes associated
with antigenic stimulation. Their conclusion was that these changes represented
immuneactivity against the tumour, with thesecondaryhypothesis that a chronic
antigenic stimulus is needed to give the gross changes found. The further
experiments ofSymes (1965, 1966) support thishypothesis. Also Bard and Pilch
(1965) have shown, in mice, that splenectomy abolishes isoimmunity induced to
methylcholanthrene induced sarcomas.
Transplantationexperiments were notusedby WoodruffandSymes to discover
whether the A-strain carcinomas they used possessed tumour sIpecific antigens.
Similar tumours in the hands of other investigators have not been shown to be
antigenic by the usual transplantation tests; however they probably have com-
paratively weak antigens, as shown by their response to attack with specifically
sensitized lymphocytes, (Woodruff and Symes,' 1-962c). ChemicaHy induced rat
sarcomas are known to possess tumour specific antigens. A demonstration,of
splenomegaly in the presence of these tumours is essential to the hypothesis of
WoodruffandSymes, and in the present paper considerablesplenicenlargement is
demonstrated tobe theresponse.tothegrowthofbothprimary andisotransplanted
methylcholanthrene tumours in the rat; the histology of the spleens seems-much
the same as that describedby Woodruffand Symes (1962a).
The spleen size found during growth of the methylcholanthrene sarcomas is
proportional to the size of the tumour (Table 111), as both Symes (1965) and
Edwards (1966) have reported with different types of tumour.
Tumourspecificantigens seem to behavehkeweakhistocompatabilityantigens.'
If the spleen changes represent a reaction to these antigens then a reaction to
foreign histocompatability ant'igens ofnormal tissues shouldgive simil'ar changes.
Animals rejecting first set skin homografts (Experiment 2) showed some splenic
enlargement, but their spleens were not as large as those seen accompanying
tumour growth. It was thought that this was because they had been exposed to
antigen for a shorter time than had tumour bearing animals. Experiment 4,
in which animals were chronically exposed to allogeneic skin and still failed to
produce spleens as large as those accompanying large tumours, seems to dismiss
this hypothesis.
Rats sensitized to allogeneic methyleholanthrene tumours (Experiment 3)
had greater spleens than the other groups of animals in these experiments. The
antigenic difference between donor andrecipient inExperiment 2 on skinallograft
rejection, and Experiment 3 on tumour allograftrejection was ofthe same order,
andyet there was a considerable difference inspleen size.
The experiments ofSymes (1965, 1966) on the spleen changes associated with
tumourgrowth, after tumour passage in normal and immuno-suppressed animals,
arguestronglyinfavourofsplenomegalybeing areaction to thepresence oftumour
specificantigen. Ifthishypothesis is accepted, it would appear from ourexperi- mentalfindings that neither the duration ofexposure to antigen nor the antigenic
gap between donor and recipient is the major factor in the magnitude of the
splenomegaly. Rather a product offoreign antigen and of some other factor, is53_9 R. W. BLAMEY AND D. NI. D. EVANS
prolDosed. The isolated finding of a very large spleen in the recipient of a success-
ful allogeneic tumour implant is of interest.
Reticuloendothelial activity, measured by clearance of colloidal carbon, is
markedly increasedduring thegrowth ofrat sarcomas (Blamey, Crosby and Baker,
1969). However, this measurement ofreticuloendothelialactivitydoesnotparallel
the activity of the lymphoid system in transplantation immunity (Blamey,
Baker and Crosby, in press). Reticuloendothelial (phagocvtic) activity mav be
the other determining factor in spleen size.
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